| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.2 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.2 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |